BI
BVF Inc’s 4D Molecular Therapeutics FDMT Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $17.2M | Buy |
4,629,289
+68,000
| +1% | +$252K | 0.61% | 25 |
|
2025
Q1 | $14.7M | Buy |
4,561,289
+1,890,647
| +71% | +$6.11M | 0.6% | 28 |
|
2024
Q4 | $14.9M | Sell |
2,670,642
-4,712,000
| -64% | -$26.2M | 0.5% | 32 |
|
2024
Q3 | $79.8M | Buy |
7,382,642
+3,460,229
| +88% | +$37.4M | 2.33% | 12 |
|
2024
Q2 | $82.3M | Hold |
3,922,413
| – | – | 2.31% | 13 |
|
2024
Q1 | $125M | Sell |
3,922,413
-85,000
| -2% | -$2.71M | 3.44% | 4 |
|
2023
Q4 | $81.2M | Hold |
4,007,413
| – | – | 2.03% | 10 |
|
2023
Q3 | $51M | Hold |
4,007,413
| – | – | 1.38% | 20 |
|
2023
Q2 | $72.4M | Hold |
4,007,413
| – | – | 2.02% | 13 |
|
2023
Q1 | $68.9M | Hold |
4,007,413
| – | – | 2.52% | 13 |
|
2022
Q4 | $89M | Hold |
4,007,413
| – | – | 3.76% | 6 |
|
2022
Q3 | $32.2M | Hold |
4,007,413
| – | – | 1.33% | 27 |
|
2022
Q2 | $28M | Buy |
4,007,413
+1,342,892
| +50% | +$9.37M | 1.35% | 25 |
|
2022
Q1 | $40.3M | Buy |
2,664,521
+658,659
| +33% | +$9.96M | 1.61% | 22 |
|
2021
Q4 | $44M | Hold |
2,005,862
| – | – | 1.6% | 20 |
|
2021
Q3 | $54.1M | Hold |
2,005,862
| – | – | 2.11% | 14 |
|
2021
Q2 | $48.3M | Buy |
2,005,862
+974,792
| +95% | +$23.5M | 1.81% | 14 |
|
2021
Q1 | $44.7M | Sell |
1,031,070
-75,000
| -7% | -$3.25M | 1.68% | 20 |
|
2020
Q4 | $45.8M | Buy |
+1,106,070
| New | +$45.8M | 1.8% | 17 |
|